Last edition
News about "Amyloid Beta"
AlzeCure Receives USD 10 Million Upfront Payment from Eli Lilly for Alzheimer's Drug Programme
AlzeCure Pharma has received a USD 10 million upfront payment from Eli Lilly, completing the initial transaction for global rights to its Alzstatin Alzheimer's programme and ACD680.
Amyloid-beta | 20/08/2026 | By News Bureau
NeuroSense Reports Positive Phase 2 Biomarker Results for PrimeC in Alzheimer's Disease Trial
PrimeC shows encouraging biomarker activity in Phase 2 Alzheimer’s study, supporting its potential as a multi-target therapy for neurodegenerative diseases.
Amyloid Beta | 26/06/2026 | By News Bureau | 195
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy